Jul 29, 2016 - Sanofi (NYSE:SNY)Q2 2016 Earnings CallJuly 29, 2016 8:30 am ETExecutivesGeorge Grofik - Vice President Investor Relations, SanofiOlivier Brandicourt - Chief Executive Officer & DirectorElias E. Zerhou
Jul 29, 2016 - Medivation (MDVN +1.3%) has asked for indications of interest by mid-August, CNBC's David Faber says, with a number of pursuers in the mix. Earlier this mo
Jul 25, 2016 - Bristol-Myers Squibb (BMY), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.12% last quarter.
Jul 25, 2016 - Celgene Corporation (CELG), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.38% last quarter.
Jul 25, 2016 - Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen
Jul 22, 2016 - Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22, 2016 - Actelion (ALIOF) reported second-quarter 2016 earnings of $2.13 per American Depository Receipt, up from the year-ago figure of $1.60.
Jul 14, 2016 - Pfizer (PFE) announced findings from two pivotal phase III studies on crisaborole for the treatment of patients with mild-to-moderate atopic dermatitis.
Jul 12, 2016 - Amgen's (AMGN) PCSK9 inhibitor Repatha becomes the first and the only one to gain FDA approval for a monthly single-dose administration.
May 01, 2016 - Sanofi SA (NYSE:SNY) Q1 2016 Earnings Conference Call April 29, 2016 08:30 AM ET Executives Sebastien Martel - VP, IR Olivier Brandicourt - CEO Jerome Contamine - EVP & CFO Pascale Witz - EVP, Dia